Banced Corp Lowers Position in CVS Health Corporation (CVS)
Banced Corp trimmed its position in shares of CVS Health Corporation (NYSE:CVS) by 3.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,924 shares of the pharmacy operator’s stock after selling 235 shares during the period. Banced Corp’s holdings in CVS Health Corporation were worth $477,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. boosted its holdings in CVS Health Corporation by 3.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock valued at $13,840,000 after purchasing an additional 5,478 shares in the last quarter. Fiduciary Trust Co. boosted its holdings in CVS Health Corporation by 1.2% during the first quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock valued at $28,732,000 after purchasing an additional 4,265 shares in the last quarter. British Columbia Investment Management Corp boosted its holdings in CVS Health Corporation by 3.7% during the first quarter. British Columbia Investment Management Corp now owns 561,299 shares of the pharmacy operator’s stock valued at $44,062,000 after purchasing an additional 19,794 shares in the last quarter. Bahl & Gaynor Inc. boosted its holdings in CVS Health Corporation by 1.1% during the first quarter. Bahl & Gaynor Inc. now owns 14,922 shares of the pharmacy operator’s stock valued at $1,171,000 after purchasing an additional 167 shares in the last quarter. Finally, Independent Advisor Alliance boosted its holdings in CVS Health Corporation by 6.7% during the first quarter. Independent Advisor Alliance now owns 26,460 shares of the pharmacy operator’s stock valued at $2,038,000 after purchasing an additional 1,652 shares in the last quarter. Hedge funds and other institutional investors own 81.49% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This story was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/09/23/banced-corp-lowers-position-in-cvs-health-corporation-cvs.html.
In related news, COO Jonathan C. Roberts sold 85,743 shares of the business’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $83.14, for a total value of $7,128,673.02. Following the transaction, the chief operating officer now owns 119,555 shares in the company, valued at $9,939,802.70. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Helena Foulkes sold 20,333 shares of the business’s stock in a transaction on Monday, June 26th. The shares were sold at an average price of $80.00, for a total transaction of $1,626,640.00. Following the completion of the transaction, the executive vice president now owns 59,301 shares in the company, valued at approximately $4,744,080. The disclosure for this sale can be found here. In the last 90 days, insiders sold 716,411 shares of company stock worth $58,277,271. 0.61% of the stock is owned by company insiders.
A number of equities research analysts have weighed in on CVS shares. Jefferies Group LLC reaffirmed a “hold” rating and set a $82.00 price objective on shares of CVS Health Corporation in a report on Friday, June 9th. Cowen and Company reaffirmed an “outperform” rating and set a $86.00 price objective on shares of CVS Health Corporation in a report on Tuesday, June 13th. Royal Bank Of Canada started coverage on CVS Health Corporation in a report on Tuesday. They set an “outperform” rating and a $95.00 price objective on the stock. ValuEngine downgraded CVS Health Corporation from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Leerink Swann set a $90.00 price objective on CVS Health Corporation and gave the company a “buy” rating in a report on Tuesday, June 27th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $90.58.
Shares of CVS Health Corporation (NYSE CVS) traded up 0.09% during mid-day trading on Friday, hitting $79.63. 6,534,109 shares of the company’s stock traded hands. The company has a market cap of $80.95 billion, a PE ratio of 15.86 and a beta of 0.92. The firm has a 50-day moving average of $79.11 and a 200 day moving average of $78.98. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $90.85.
CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.02. The company had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. CVS Health Corporation’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.32 earnings per share. Equities research analysts predict that CVS Health Corporation will post $5.88 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be issued a $0.50 dividend. The ex-dividend date is Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.51%. CVS Health Corporation’s payout ratio is 39.92%.
CVS Health Corporation Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.